- Invitae is a leader in advanced medical genetics.
- UnitedHealthcare created a "Preferred Laboratory Network (PLN)". Invitae has been selected as one of the seven lab companies.
- LMT 1- 18.9$ (25 % of the planned investment amount)
- LMT 2- 17.34$ (55 % of the planned investment amount)
- LMT 3- 14.79$ (20 % of the planned investment amount)
Comments and likes are greatly appreciated.
I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions and this is not a call for investment. I am not receiving compensation for it . I have no business relationship with any company whose stock is mentioned in this article.